STaR Trial: Multiple Ligament Knee Injuries

August 7, 2023 updated by: James J. Irrgang, University of Pittsburgh

STaR (Surgical Timing and Rehabilitation) Trial for Multiple Ligament Knee Injuries

The purpose of this study is to investigate effects of timing of surgery (early vs. delayed) and timing of post-operative rehabilitation (early vs. delayed) for the treatment of military personnel and civilians that sustain a multiple ligament knee injury. To achieve this overall objective of this project, we will conduct two parallel randomized clinical trials. For the first study we will randomize individuals to timing of surgery and timing of post-operative rehabilitation. We hypothesize that early surgery, early rehabilitation and the combination of early surgery with early rehabilitation will lead to an earlier and more complete return to pre-injury military duty, work and sports and better patient-reported physical function. In the second study, those whose timing of surgery can not be randomized, will be only randomized to early or delayed rehabilitation. For this study, we hypothesize that early rehabilitation will lead to an earlier and more complete return to pre-injury military duty, work and sports activity and better patient-reported physical function.

Study Overview

Detailed Description

Background:

Multiple ligament knee injuries (MLKIs) represent a spectrum of injury ranging from disruption of two ligaments to all four major ligaments of the knee. Concomitant injuries may include fractures and injuries to vessels, nerves, tendons, menisci and/or articular cartilage. As such, the treatment of MLKIs creates multiple complex problems fraught with complications such as poor wound healing, arthrofibrosis, neurovascular injuries, persistent pain and instability, and post-traumatic osteoarthritis. Following MLKI, individuals are frequently limited with higher demand activities such as in military training, physical labor and sports. Return to duty after combat-related MLKIs has been reported to be as low as 41% and substantially lower than return to work reported for civilians.

There is controversy related to the optimal timing of surgery and post-operative rehabilitation for the treatment of MLKIs. Early surgical intervention for MLKIs has been advocated, however this may be associated with an increased risk for arthrofibrosis. Conversely, delayed surgery may be associated with persistent instability. The best evidence for timing of rehabilitation is based on evidence following ACL reconstruction, where early post-operative rehabilitation is the current standard of care. However, because of the frequency of soft tissue repair procedures, post-operative rehabilitation after surgery for a MLKI typically involves a period of non-WB and delayed ROM exercises. Due to the lack of evidence for the timing of surgery and post-operative rehabilitation, a large scale trial is needed to optimize the outcomes for these potentially devastating injuries. Therefore, this multicenter clinical trial will investigate the effects of timing of surgery and post-op rehabilitation to optimize return to military duty, work and sports for military personnel and civilians with a MLKI.

Objectives, Aims and Hypothesis:

The overall objective of this project is to investigate the effects of timing of surgery (early vs. delayed) and timing of post-op rehabilitation (early vs. delayed) for treatment of MLKIs. To achieve this objective, we will conduct two parallel randomized clinical trials. The related aims and hypotheses are:

Specific Aim 1 and Hypothesis: Determine the effects of timing of surgery and post-op rehabilitation on time to return to pre-injury level of military duty, work and sports and patient-reported physical function. We hypothesize that early surgery, early rehabilitation and the combination of early surgery with early rehabilitation will lead to an earlier and more complete return to pre-injury military duty, work and sports and better patient-reported physical function.

Specific Aim 2 and Hypothesis: For those individuals whose timing of surgery can not be randomized, determine the effects of timing of rehabilitation on time to return pre-injury level of military duty, work and sports and patient-reported physical function. We hypothesize that early rehabilitation will lead to an earlier and more complete return to pre-injury military duty, work and sports activity and better patient-reported physical function.

Overview of Research Procedures:

Male and female military personnel and civilians between the ages of 16 and 55 with a MLKI without a history of prior knee ligament reconstruction that do not have a vascular injury, poly-trauma or a traumatic brain injury will be eligible to participate. After obtaining informed consent, subjects will undergo a preoperative evaluation, including collection of baseline demographics, activity level, and a physical examination.

To address Aim 1, 392 individuals with a MLKI that present within 6 weeks of injury will be randomized to early (within 6 weeks of injury) or delayed (12 to 16 weeks after injury) surgery and early (WB and unrestricted ROM exercises starting first week after surgery) vs. delayed (knee brace locked in extension, no range of motion exercises and non-weightbearing gait for the first 4 weeks after surgery). To address Aim 2, 298 individuals with a MLKI that present greater than 6 weeks after injury, have an injury that precludes randomization to early or delayed surgery as well as those that refuse surgical randomization will be eligible to participate in the trial that compares only early vs. delayed rehabilitation. Randomization will be stratified by study site and knee ligament injury pattern.

Collection of Baseline Demographics and Activity Level:

Following consent and screening, baseline demographic and pre-injury level of military duty, work and sports participation will be recorded. The demographic information to be recorded includes age, sex, weight, height, body mass index (BMI), marital status, education level, pre-injury military duty, work and sports, smoking history and insurance status.

Military Duty - For military personnel, to measure military duty prior to injury we will record the Military Occupational Specialty Physical Demand Classification and will ask three questions from the Injury Surveillance Survey (ability to perform Annual Physical Fitness Test; Deployability and Specific MOS Duties).

Work Activity - To measure work activity prior to injury, we will use the Cincinnati Occupational Rating Scale. Additionally, we will record the individual's pre-injury employment status (work regular duty full time, work regular duty part-time etc.) and occupation.

Sports Activity and Participation - We will use the Marx Activity Rating Scale to measure the subject's level of sports activity in the year prior to injury. To assess sports participation, we will also record the type (very strenuous, strenuous etc.) and frequency (4-7 times per week, 1-3 times per week etc.) of sports participation as well as the specific sport(s) the individual participated in prior to injury.

Baseline Clinical Examination:

A standard of care baseline clinical examination will be performed by the individual's attending orthopaedic surgery. The examination will include assessment of pain, range of motion (ROM), ligament laxity, sensory and neurovascular status (pulses, sensory & motor nerve function). Additionally, standard of care radiographs and MRI will be reviewed to identify fractures and document the ligament injury. The information from the baseline clinical examination will be used to confirm final eligibility in the surgical and post-operative rehabilitation trial or the post-operative rehabilitation only trial.

Interventions:

Aim 1 - Randomization to Early vs. Delayed Surgery and Post-Operative Rehabilitation - Subjects enrolled in the clinical trial for Aim 1 will be randomized to one of four groups: early surgery/early rehabilitation, early surgery/delayed rehabilitation, delayed surgery/early rehabilitation or delayed surgery/delayed rehabilitation.

Those randomized to early surgery will undergo surgery within six weeks of injury and those that are randomized to delayed surgery will undergo surgery 12 to 16 weeks after injury. In all cases, surgery will be in accordance with the principles of anatomic repair/reconstruction of injured structures in a manner that will allow for early range of motion. Surgical reconstruction with allograft or autograft will be performed for mid-substance tears of the ACL and/or posterior cruciate ligament (PCL). Repair or reconstruction will be performed for injury to the medial collateral ligament (MCL) and the posterolateral corner (PLC) structures (fibular collateral ligament, popliteus tendon, and popliteofibular ligament). Injuries to the biceps femoris tendon or iliotibial band will be addressed as necessary. Medial and lateral meniscus tears will be repaired or debrided at the time of surgery. Neuropraxic nerve injuries will not necessitate early intervention; however, if a neurotmesis injury is discovered on MRI, then early intervention for primary repair, grafting or benign neglect may be warranted. All surgical findings and procedures will be documented on electronic surgical case report forms.

Two post-operative rehabilitation protocols have been created, differing only in the time to begin weightbearing (WB) and ROM exercises. After surgery, all individuals will be placed in a hinged brace that is locked in extension. Individuals randomized to early rehabilitation will begin WB as tolerated (WBAT) with the brace locked in full extension and unrestricted ROM approximately 1 week after surgery at the time of the first post-operative visit. Individuals in this group will unlock the brace for ROM exercises, but will keep the brace locked at all other times until the criteria to unlock the brace are met. Weightbearing will be gradually progressed to full WB no earlier than 3 weeks after surgery pending achievement of the criteria for doing so.

Those allocated to delayed rehabilitation will be placed in a knee brace locked in extension, with no range of motion exercise and will utilize a non-weightbearing gait for the first 4 weeks after surgery.

Immediately after surgery both groups will begin isometric quadriceps exercises with the knee in full extension (quad sets, straight leg raises) and high intensity neuromuscular electrical stimulation (NMES) for the quadriceps will be utilized. Use of the post-op brace will be discontinued no earlier than 6 weeks after surgery pending achievement of the criteria to do so. In the Motor Control and Functional Optimization phases of rehabilitation, progression to increasingly demanding activities will be time- and criterion-based to ensure that the individual is advanced safely to reduce the risk of further injury.

Aim 2 - Randomization to only Early vs. Delayed Rehabilitation - Subjects enrolled in the trial for Aim 2 will undergo anatomic surgical repair/reconstruction of the injured structures as described above, however the timing of surgery will be determined by the surgeon and patient after consideration of the individual's specific circumstances related to the nature and extent of the MLKI, associated injuries and timing of presentation. Following surgery, individuals will be randomized to undergo either early or delayed rehabilitation as described above.

Clinical Follow-Up Visits:

Information gathered during standard of care clinical follow-up visits will be prospectively collected at 1 week and 1, 3, 6 and 9 to 12 months after the date of surgery. This information will be documented and will serve to provide additional outcomes related to post-operative recovery. The information will include pain, pain medication usage, joint effusion, wound and neurovascular status, ROM, WB status, use of a post-op rehabilitation brace, imaging and/or laboratory tests ordered and completed, complications and adverse events, additional surgical procedures and military duty, work and sports status. Knee laxity will also be assessed 3, 6 and 9 to 12 months after surgery.

Research Follow-Up Visits:

Subjects in all studies will be followed for 24 months. The primary outcome will be time to return to pre-injury military duty, work and sports. To precisely determine the time to return to military duty, work and sports, we will administer a brief Return to Activity Monitoring Survey on a monthly basis starting 6 months after randomization and continuing through the 24-month follow-up. Patient-reported physical function as measured with the Activity Limitation Scale of the Multiple Ligament Quality of Life (MLQoL) Questionnaire will serve as a co-primary outcome and will be assessed 6, 12 and 24 months after randomization. Secondary outcome measures will include additional knee-specific and general patient-reported measures of physical function and health-related quality of life. We will also collect measures of kinesiophobia, resiliency and functional comorbidities because these constructs may affect return to military duty, work and sports.

Study Type

Interventional

Enrollment (Estimated)

690

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15213
        • Recruiting
        • University of Pittsburgh
        • Contact:
        • Contact:
        • Principal Investigator:
          • James J Irrgang, PT, PhD
        • Principal Investigator:
          • Volker Musahl, MD
        • Sub-Investigator:
          • Andrew D Lynch, PT, PhD
        • Sub-Investigator:
          • Charity G Patterson, PhD
        • Sub-Investigator:
          • Alexandra Gil, PT, PhD
        • Sub-Investigator:
          • Bryson Lesniak, MD
        • Sub-Investigator:
          • Peter Siska, MD
        • Sub-Investigator:
          • Ivan Tarkin, MD
        • Sub-Investigator:
          • Stephen Rabuck, MD
        • Sub-Investigator:
          • Jonathan Hughes, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 53 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

For the clinical trials for both aims, male and female military personnel and civilians between the ages of 16 and 55 with a MLKI (defined as a complete grade III injury of two or more ligaments) will be eligible to participate. Individuals with a nerve injury or biceps or popliteus tendon rupture or avulsion will not be excluded from participation in either trial.

Individuals will be excluded from both trials if they:

  1. Prior knee ligament surgery of the involved knee;
  2. Torn or avulsed patellar or quadriceps tendon;
  3. Periarticular or long bone fracture that is anticipated to preclude weight-bearing after surgery;
  4. Require use of an external fixator for greater than 10 days;
  5. Planned staged surgical treatment;
  6. Unable to weight bear on the contralateral uninjured leg;
  7. Traumatic brain injury (TBI) that limits their ability to participate in their post-operative care;
  8. Surgical procedures that precludes early weight-bearing or range of motion.
  9. Any condition that would preclude the ability to comply with post-operative guidelines.

Additional Eligibility Criteria for Participation in Aim 1 - Randomization to Both Timing of Surgery and Post-Operative Rehabilitation

To be eligible to participate in the study for Aim 1 individuals with a MLKI must present to orthopaedic surgery in time to undergo definitive surgery within 6 weeks of injury if randomized to the early surgery group.

Individuals will also be ineligible to participate in the study for Aim 1 if they have:

  1. Vascular injury that dictates timing of surgery;
  2. Poly trauma that precludes surgery within 6 weeks of injury;
  3. Skin or soft tissue injury that precludes early surgery and rehabilitation.

Additional Eligibility Criteria for Participation in Aim 2 - Randomization to Only timing of Post-operative Rehabilitation

Subjects with a MLKI that present to orthopaedic surgery at a time that precludes randomization to early surgery or have an injury that precludes randomizing the timing of surgery (such as a vascular injury) as well as those that refuse randomization to the timing of surgery will be eligible to participate in the study for Aim 2 which randomizes subjects to only early vs. delayed rehabilitation.

Individuals will also be excluded from the trial that randomizes only the timing post-operative rehabilitation if they have:

  1. Vascular surgery that precludes early rehabilitation;
  2. Polytrauma that limits ability to participate in post-operative care;
  3. Skin or soft tissue injury that precludes early rehabilitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Surgery & Early Rehab
Individuals with a MLKI that present within 6 weeks of injury will be randomized to early surgery and early rehabilitation.
Subjects will undergo surgery within 6 weeks after injury.
Subjects will undergo rehabilitation that will include unrestricted range of motion exercises and use of a weightbearing as tolerated gait starting after the first post-operative visit with the surgeon.
Experimental: Early Surgery & Delayed Rehab
Individuals with a MLKI that present within 6 weeks of injury will be randomized to early surgery and delayed rehabilitation.
Subjects will undergo surgery within 6 weeks after injury.
Subjects will undergo rehabilitation that will include use of a knee brace locked in extension, no range of motion exercises and use of non-weightbearing gait for the first 4 weeks after surgery.
Experimental: Delayed Surgery & Early Rehab
Individuals with a MLKI that present within 6 weeks of injury will be randomized to delayed surgery and early rehabilitation.
Subjects will undergo rehabilitation that will include unrestricted range of motion exercises and use of a weightbearing as tolerated gait starting after the first post-operative visit with the surgeon.
Subjects will undergo surgery 12 to 16 weeks after injury.
Experimental: Delayed Surgery & Delayed Rehab
Individuals with a MLKI that present within 6 weeks of injury will be randomized to delayed surgery and delayed rehabilitation.
Subjects will undergo rehabilitation that will include use of a knee brace locked in extension, no range of motion exercises and use of non-weightbearing gait for the first 4 weeks after surgery.
Subjects will undergo surgery 12 to 16 weeks after injury.
Experimental: Early Rehab Only
Individuals not eligible for randomization to timing of surgery will be randomized to only early rehabilitation.
Subjects will undergo rehabilitation that will include unrestricted range of motion exercises and use of a weightbearing as tolerated gait starting after the first post-operative visit with the surgeon.
Experimental: Delayed Rehab Only
Individuals not eligible for randomization to timing of surgery will be randomized to only delayed rehabilitation.
Subjects will undergo rehabilitation that will include use of a knee brace locked in extension, no range of motion exercises and use of non-weightbearing gait for the first 4 weeks after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Return to Pre-Injury Level of Activity
Time Frame: Monthly starting at 6 months post-randomization and continuing to 24 months
Time to return to pre-injury level military duty, work and/ sports
Monthly starting at 6 months post-randomization and continuing to 24 months
Patient-Reported Physical Function - Activity Limitation Scale of the Multiple Ligament Quality of Life (MLQoL) Questionnaire
Time Frame: 24 months following randomization
Activity Limitation Scale of the Multiple Ligament Quality of Life scale measures the degree of difficulty an individual with a multiple ligament knee injury experiences with simple and complex activities as related to his/her knee. The Activity Limitation Scale score ranges from 0 to 100 with a score of 0 representing no activity limitations due to the multiple ligament knee injury.
24 months following randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Impairment Scale of the Multiple Ligament Quality of Life (MLQoL) Questionnaire.
Time Frame: 24 months following randomization
Physical Impairment Scale measures the physical symptoms experienced by an individual with a multiple ligament knee injury. The Physical Impairment Scale score ranges from 0 to 100 with a score of 0 representing no physical symptoms due to the multiple ligament knee injury.
24 months following randomization
Emotional Impairment Scale of the Multiple Ligament Quality of Life (MLQoL) Questionnaire
Time Frame: 24 months following randomization
Emotional Impairment Scale measures the changes in mood and emotions experienced by an individual with a multiple ligament knee injury. The Emotional Impairment Scale score ranges from 0 to 100 with a score of 0 representing no changes in mood and emotions due to the multiple ligament knee injury.
24 months following randomization
Social Involvement Scale of the Multiple Ligament Quality of Life (MLQoL) Questionnaire
Time Frame: 24 months following randomization
Social Involvement Scale measures the social limitations experienced by an individual with a multiple ligament knee injury. The Social Involvement Scale score ranges from 0 to 100 with a score of 0 representing no social limitations due to the multiple ligament knee injury.
24 months following randomization
International Knee Documentation Committee Subjective Knee Form (IKDC-SKF)
Time Frame: 24 months following randomization
The International Knee Documentation Committee Subjective Knee Form is an 18-item knee-specific patient-reported measure of symptoms, function and sports activities for individuals with a variety of knee conditions, including MLKIs. The International Knee Documentation Committee Subjective Knee Form score ranges from 0 to 100 with higher scores indicating the absence of symptoms and higher levels of function and sports activity.
24 months following randomization
Patient Reported Outcome Measurement Information System (PROMIS) Physical Function (PF) Scale
Time Frame: 24 months following randomization
Patient Reported Outcome Measurement Information System Physical Function Scale consists of an item bank of 121 items that assesses physical function regardless of the health condition present that can be administered as a computer adaptive test (CAT) or through the use of short forms. The Physical Function scale scores transformed to a T-score in which a score of 50 represents the US population average with a standard deviation of 10 indicating the population standard deviation.
24 months following randomization
Patient Reported Outcome Measurement Information System (PROMIS) Global 1- Global 10
Time Frame: 24 months following randomization
The Patient Reported Outcome Measurement Information System (PROMIS) Global 10 is a 10-item patient-reported measure of physical and emotional health. The items are combined into two scores, one representing global physical function, the other representing global mental function. The Physical and Emotional Function scores are scores transformed to a T-score in which a score of 50 represents the US population average with a standard deviation of 10 indicating the population standard deviation.
24 months following randomization
Patient Acceptable Symptom State (PASS)
Time Frame: 24 months following randomization
The Patient Acceptable Symptom State is a single question that measures an individual's satisfaction with the state of their knee health. The Patient Acceptable Symptom State question is answered Yes or No. A response of Yes indicates that the individual is satisfied with his/her current symptom state.
24 months following randomization
Global Rating of Change (GRC)
Time Frame: 24 months following randomization
The Global Rating of Change asks the individual to compare his/her current functional status to his/her functional status at the time of enrollment/post-injury. The responses for the Global Rating of Change range from +7 (greatly better) to -7 (greatly worse). Higher scores representing greater improvement in function since the time of enrollment/post-injury.
24 months following randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 31, 2018

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

May 8, 2018

First Submitted That Met QC Criteria

May 30, 2018

First Posted (Actual)

June 1, 2018

Study Record Updates

Last Update Posted (Actual)

August 14, 2023

Last Update Submitted That Met QC Criteria

August 7, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY20110374
  • W81XWH-17-2-0073 (Other Grant/Funding Number: United States Department of Defense)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A public-use version of the dataset will be constructed by the DCC with contents to be determined jointly by the study PIs and the DCC Director. Copies of the public-use version of the dataset will be housed at the DCC on a secure server along with suitable documentation of this dataset. The public-use version of the dataset will be exported by CRF in one or more files in simple, widely-accessible formats, e.g., .xls, .csv, and/or SAS datasets. Documentation will be in .pdf files.

IPD Sharing Time Frame

The public-use version of the database will be made available 2 years after the study's main paper is published.

IPD Sharing Access Criteria

Outside investigators wishing to conduct analyses using the data will submit a request with objectives, methods, and analysis plan to the PI and the Director of the DCC. Once the request is approved, the public-use version of the dataset, with documentation, will be sent by secure email using e-mail, ftp, or other mutually agreeable transmission method.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Dislocations

Clinical Trials on Early Surgery

3
Subscribe